Synonyms
Status
Molecule Category UNKNOWN
UNII P7T269PR6S
EPA CompTox DTXSID90236452

Structure

InChI Key MZZLGJHLQGUVPN-HAWMADMCSA-N
Smiles COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C
InChI
InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C30H25F10NO3
Molecular Weight 637.51
AlogP 9.76
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 6.0
Polar Surface Area 38.77
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 44.0

Bioactivity

Mechanism of Action Action Reference
Cholesteryl ester transfer protein inhibitor INHIBITOR PubMed
Protein: Cholesteryl ester transfer protein

Description: Cholesteryl ester transfer protein

Organism : Homo sapiens

P11597 ENSG00000087237
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Ion channel Other ion channel Pore-forming toxins (proteins and peptides)
- 17-60 - - 84-94
Assay Description Organism Bioactivity Reference
Inhibition of human recombinant CETP-mediated cholesteryl ester transfer activity at 100 uM after 1 hr by fluorescent cholesteryl esters transfer assay relative to control Homo sapiens 94.0 %
Inhibition of human recombinant CETP-mediated cholesteryl ester transfer activity after 1 hr by fluorescent cholesteryl esters transfer assay Homo sapiens 17.2 nM
Inhibition of CETP-mediated neutral lipid transfer by fluorometric analysis None 17.2 nM
Inhibition of CETP in human plasma assessed as reduction in fluorescent intensity by fluorescence analysis Homo sapiens 46.0 nM
Inhibition of full-length human recombinant CETP expressed in CHO cells by BODIPY-CE dye based fluorescence assay Homo sapiens 60.0 nM
Inhibition of recombinant CETP (unknown origin) assessed as inhibition of BODIPY-labeled cholesteryl transfer to fluorescent substrate by fluorimetric assay Homo sapiens 40.0 nM
Inhibition of recombinant full length human CETP expressed in CHO cells assessed as reduction in BODIPY-CE transfer measured after 1 to 3 hrs by fluorescence assay Homo sapiens 40.0 nM
Inhibition of CETP in human plasma measured every 30 mins for 120 mins by fluorescence method Homo sapiens 18.0 nM
Inhibition of recombinant human CETP after 3 hrs using fluorescent cholesteryl containing HDL after 3 hrs by fluorescence assay Homo sapiens 33.8 nM
Inhibition of recombinant human CETP at 10 uM using fluorescent cholesteryl containing HDL after 3 hrs by fluorescence assay Homo sapiens 84.1 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 26.88 % SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 14.48 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.02 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.22 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.22 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 0.02 %
Inhibition of human CETP at 10 uM relative to control Homo sapiens 88.4 %
Inhibition of human CETP Homo sapiens 36.0 nM
Inhibition of CETP in 95% human serum assessed as inhibition of transfer of [3H] cholesteryl oleate or [3H] triolein between LDL and HDL Homo sapiens 53.0 nM
In vivo inhibition of CETP in human assessed as reduction in LDL-C level Homo sapiens 40.0 %
Inhibition of recombinant CETP (unknown origin) assessed as inhibition of transfer of [3H]cholesteryl oleate or [3H]triolein between exogenous [3H]LDL in 95% human serum by liquid scintillation analysis Homo sapiens 45.0 nM
Inhibition of recombinant CETP (unknown origin) assessed as inhibition of transfer of [3H]cholesteryl oleate or [3H]triolein using exogenous LDL and HDL in 2% human serum by liquid scintillation analysis Homo sapiens 17.0 nM
In vivo inhibition of CETP in transgenic mouse assessed as CETP activity measured at 100 mg/kg, po treated for 2 weeks relative to control Mus musculus 80.0 %

Cross References

Resources Reference
ChEMBL CHEMBL1800807
DrugBank DB06630
FDA SRS P7T269PR6S
Guide to Pharmacology 8400
PubChem 11556427
SureChEMBL SCHEMBL531448
ZINC ZINC000068087592